So far, no published studies have specifically explored the association of platelet membrane glycoprotein (HPA-2a/b, GP VI T13254C, and GP Ibα VNTR) polymorphisms with the risk of CAD. The gene discussed is GP1BA; the disease is coronary artery disorder.